Janelle Sharkey

1.7k total citations · 1 hit paper
18 papers, 1.4k citations indexed

About

Janelle Sharkey is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Janelle Sharkey has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Janelle Sharkey's work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (8 papers) and CAR-T cell therapy research (6 papers). Janelle Sharkey is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (8 papers) and CAR-T cell therapy research (6 papers). Janelle Sharkey collaborates with scholars based in Australia, Japan and United States. Janelle Sharkey's co-authors include Mark J. Smyth, Nicole M. McLaughlin, Sandra Pommey, John Stagg, Delphine Denoyer, Karen M. Dwyer, Upulie Divisekera, Jeremy B. Swann, Anabel Silva and Matthew D. Vesely and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Janelle Sharkey

18 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

2010 479 citations John Stagg, Upulie Divisekera et al. Proceedings of the National Academy of Sciences profile →

Peers

Janelle Sharkey

IMMUN

ONCOL

PHYSI

EPIDE

Abdelaziz Gdoura France

Roland Fiskesund Sweden

Scott D. Bercury United States

Leonardo Vargas Sweden

Neelakshi R. Jog United States

Wenqian Dong China

Yingchi Zhang China

Francesca Romana Mariotti Italy

Norimasa Matsushita Japan

Khoa Nguyen United States

Abdelaziz Gdoura France

Janelle Sharkey

361 ×0.5

IMMUN

178 ×0.3

ONCOL

253 ×0.6

33 ×0.1

PHYSI

114 ×1.2

EPIDE

Citations per year, relative to Janelle Sharkey Janelle Sharkey (= 1×) peers Abdelaziz Gdoura

Countries citing papers authored by Janelle Sharkey

Since Specialization

Citations

This map shows the geographic impact of Janelle Sharkey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janelle Sharkey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janelle Sharkey more than expected).

Fields of papers citing papers by Janelle Sharkey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janelle Sharkey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janelle Sharkey. The network helps show where Janelle Sharkey may publish in the future.

Co-authorship network of co-authors of Janelle Sharkey

This figure shows the co-authorship network connecting the top 25 collaborators of Janelle Sharkey. A scholar is included among the top collaborators of Janelle Sharkey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janelle Sharkey. Janelle Sharkey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Yong, Carmen S., Janelle Sharkey, Wei‐Zen Wei, et al.. (2015). Embryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b Gene. PLoS ONE. 10(9). e0136817–e0136817. 13 indexed citations

Teng, Michele W.L., Jeremy B. Swann, Bianca von Scheidt, et al.. (2010). Multiple Antitumor Mechanisms Downstream of Prophylactic Regulatory T-Cell Depletion. Cancer Research. 70(7). 2665–2674. 58 indexed citations

Westwood, Jennifer A., Phillip K. Darcy, Janelle Sharkey, et al.. (2010). Three agonist antibodies in combination with high-dose IL-2 eradicate orthotopic kidney cancer in mice. Journal of Translational Medicine. 8(1). 42–42. 25 indexed citations

Stagg, John, Upulie Divisekera, Nicole M. McLaughlin, et al.. (2010). Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proceedings of the National Academy of Sciences. 107(4). 1547–1552. 479 indexed citations breakdown →

Westwood, Jennifer A., Nicole M. Haynes, Janelle Sharkey, et al.. (2009). Toll-Like Receptor Triggering and T-Cell Costimulation Induce Potent Antitumor Immunity in Mice. Clinical Cancer Research. 15(24). 7624–7633. 20 indexed citations

Teng, Michele W.L., Simon Yue, Janelle Sharkey, Mark A. Exley, & Mark J. Smyth. (2009). CD1d Activation and Blockade: A New Antitumor Strategy. The Journal of Immunology. 182(6). 3366–3371. 18 indexed citations

Teng, Michele W.L., Janelle Sharkey, Nicole M. McLaughlin, Mark A. Exley, & Mark J. Smyth. (2009). CD1d-Based Combination Therapy Eradicates Established Tumors in Mice. The Journal of Immunology. 183(3). 1911–1920. 21 indexed citations

Swann, Jeremy B., Adam P. Uldrich, Janelle Sharkey, et al.. (2009). Type I natural killer T cells suppress tumors caused by p53 loss in mice. Blood. 113(25). 6382–6385. 87 indexed citations

Smyth, Mark J., Michele W.L. Teng, Janelle Sharkey, et al.. (2008). Interleukin 21 Enhances Antibody-Mediated Tumor Rejection. Cancer Research. 68(8). 3019–3025. 23 indexed citations

10.

Swann, Jeremy B., Matthew D. Vesely, Anabel Silva, et al.. (2008). Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proceedings of the National Academy of Sciences. 105(2). 652–656. 244 indexed citations

11.

Smyth, Mark J., et al.. (2008). Cancer immunoediting: Recent progress in elimination and equilibrium. 8. 3. 1 indexed citations

12.

Stagg, John, Janelle Sharkey, Sandra Pommey, et al.. (2008). Antibodies targeted to TRAIL receptor-2 and ErbB-2 synergize in vivo and induce an antitumor immune response. Proceedings of the National Academy of Sciences. 105(42). 16254–16259. 40 indexed citations

13.

Frew, Ailsa J., Ralph K. Lindemann, Ben P. Martin, et al.. (2008). Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist. Proceedings of the National Academy of Sciences. 105(32). 11317–11322. 118 indexed citations

14.

Teng, Michele W.L., Jennifer A. Westwood, Phillip K. Darcy, et al.. (2007). Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice. Cancer Research. 67(15). 7495–7504. 55 indexed citations

15.

Sharkey, Janelle, Tiffany Khong, & Andrew Spencer. (2006). PKC412 demonstrates JNK-dependent activity against human multiple myeloma cells. Blood. 109(4). 1712–1719. 18 indexed citations

16.

Khong, Tiffany, Janelle Sharkey, & Andrew Spencer. (2005). Flavopiridol Decreases the Level of p21 and Induces Apoptosis in Human Myeloma Cell Lines.. Blood. 106(11). 5188–5188. 1 indexed citations

17.

Stitt, Alan W., Jonathan E. Moore, Janelle Sharkey, et al.. (1998). Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy.. PubMed. 39(13). 2517–23. 108 indexed citations

18.

Sharkey, Janelle, et al.. (1993). Ocular toxocariasis in a patient with repeatedly negative ELISA titre to Toxocara canis.. British Journal of Ophthalmology. 77(4). 253–254. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact